MedTrace Logo

Metabolomic Profiling in Adolescents With Obesity and Diabetes

NCT02145572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-11-03

No results posted yet for this study

Summary

The purpose of this study is to identify unique metabolite signatures associated with the development of Type 2 diabetes and diabetic kidney disease in children.

We have a sub-study, with the purpose to validate the presence of a genetic marker (DENND1A) in the urine of adolescent females with polycystic ovarian syndrome.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jane J Kim, MD · University of California, San Diego

Eligibility

Min Age
13 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2019-04-30
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02145572 on ClinicalTrials.gov